International Society For Affective Disorders - Isad
Tuesday: 09:00 - 17:00
Wednesday: 09:00 - 17:00
Thursday: 09:00 - 17:00
Friday: 09:00 - 17:00
Saturday: -
Sunday: -
About International Society For Affective Disorders - Isad
The International Society for Affective Disorders (ISAD) exists to promote research into the affective disorders
International Society For Affective Disorders - Isad Description
The International Society for Affective Disorders (ISAD) exists to promote research into the affective disorders through all relevant scientific disciplines, including genetics, neuroscience and the social and behavioural sciences. Inter-disciplinary research approaches are particularly highly valued by the society.
Although the affective disorders are not a clearly delineated group of illnesses they include unipolar and bipolar depression, generalised anxiety disorder, and more specific anxiety disorders such as agoraphobia, panic disorder and social phobia, obsessive-compulsive disorder and post traumatic stress disorder (PTSD). There is a high level of similarity and co-morbidity between these illnesses and it is sensible to consider them as a single group.
Reviews
The deadline for your posters/oral abstracts is approaching fast! We want your research! You have one week to submit it and to have the opportunity to participate in #ISAD2019 scientific program! Submit: http://bit.ly/2Rsrfaf
“Bright light therapy is used as a treatment for a number of #mental health conditions, including seasonal #AffectiveDisorder, bipolar #depression, chronic #DepressiveDisorder, and insomnia. The present research study suggests it may be useful for #dementia, too” http://bit.ly/2JDMmRM
“The ISAD Conference is the most important gathering of the #AffectiveDisorders community and is now an outstanding international meeting. We look forward to an exciting meeting that promises great scientific debate and enjoyable social interaction. We look forward to welcoming you to the Conference in November 2019! #ISAD2019 www.isadconference.org
“Repetitive transcranial magnetic stimulation (rTMS) showed efficacy in patients with major #depressive disorder (#MDD) and comorbid #anxiety, according to results from a study published in the Journal of #AffectiveDisorders” http://bit.ly/2JlBvM1
Call for Posters/Oral Abstracts! Submit your research before 24 May 2019 and have the chance to actively participate in #ISAD2019 scientific program! To submit: http://bit.ly/2Rsrfaf
“Children with early-onset #DisruptiveBehavior (DB) who have a parent with a registered #mental disorder are at increased risk for poor #psychosocial functioning in middle and late adolescence” http://bit.ly/2Pl3vAv
Be part of the 10th Conference of the International Society for #AffectiveDisorders (#ISAD2019). Register today and benefit from the early bird rates! To become a participant: http://bit.ly/2QDWoHb
“In children taking #antipsychotic medications for first-episode psychosis, quetiapine-extended release was associated with increased negative body composition and metabolic parameters when compared with aripiprazole” http://bit.ly/2PndZiM
Be part of the forthcoming #ISAD2019 Conference! This year the conference will be held in London. Join us and have the chance to explore the majestic British capital! Learn more about ISAD 2019: https://www.isadconference.org/
“The clinical characteristics associated with the presence or absence of predominant polarity (PP) in patients with #BipolarDisorder are significant enough to justify the need for differential treatment, according to study data published in the Journal of #AffectiveDisorders” http://bit.ly/2v50TNT
“Asking about #depression in more than one way can identify symptoms in different groups of postnatal women, according to study data published in the Journal of #AffectiveDisorders” http://bit.ly/2P3ODGD
“In patients with remitting #depression, higher suicidal ideation during the current depressive episode, residual symptoms at remission, and greater severity of side effects at remission may be predictors of subsequent relapse” #AffectiveDisorders http://bit.ly/2uV3oSU
You can still submit your research for #ISAD2019! The Abstract Submission Deadline has been extended. Do not hesitate and grab the opportunity to be part of our amazing scientific program. New deadline: 10 April 2019 To submit: http://bit.ly/2Rsrfaf
“Cannabidiol, or CBD, is a natural compound that has gained popularity in recent years, thanks in part to a growing body of research into its potential health benefits, which may include treating #depression.The initial results of some studies into CBD and depression look promising” http://bit.ly/2FQz55P
Call for Abstracts! We want your research! Do no hesitate and share your research with us and your international colleagues at #ISAD2019 in Birmingham. Deadline: 31 March 2019 To Submit: http://bit.ly/2Rsrfaf
“The CACNG2 gene may be associated with lithium response in patients with #BipolarDisorder, according to study data published in the Journal of Affective Disorders” http://bit.ly/2TUl3rO #AffectiveDisorders
We are delighted to welcome you to #ISAD2019: Emerging #MoodScience and Clinical Innovation and, for the second time, to its host city, #London. The ISAD Conference in the most important gathering of the #AffectiveDisorders community and is now and outstanding international meeting! See you in London! Find out more about ISAD: www.isadconference.org
“There is an increased risk for autism spectrum disorder (#ASD) in the children of parents with mood disorders, according to study results published in the Journal of Affective Disorders” http://bit.ly/2Jkr4dh #AffectiveDisorders
More about International Society For Affective Disorders - Isad
Tuesday: 09:00 - 17:00
Wednesday: 09:00 - 17:00
Thursday: 09:00 - 17:00
Friday: 09:00 - 17:00
Saturday: -
Sunday: -